VEGFA and acute kidney injury: Indeed, one article reports five cases of AKI in patients treated with vascular endothelial growth factor inhibitors (four with bevacizumab and one with sorafenib) and highlights the fact that tubular injury with focal necrosis had been seen in all five cases, possibly in addition to thrombotic microangiopathy lesions [13, 14].